Why the study?
The study was conducted to assess the health and socioeconomic impact of the Stent for Life initiative across four model regions.
Does the Stent for Life programme reduce mortality and overall costs in patients with ST-elevation myocardial infarction?
Does the Stent for Life programme reduce mortality and overall costs in patients with ST-elevation myocardial infarction?
Systematic investments to improve access to primary PCI for STEMI patients reduces mortality and net societal costs, outweighing the initial increase in healthcare costs.
Answers are grounded in this paper and cite their sources.
May support regional STEMI network investments; extends economic models but leaves open real-world generalizability.
AIMS: The Stent for Life initiative aims at the reduction of mortality in patients with ST-elevation myocardial infarction by enhancing timely access to primary percutaneous coronary intervention. To assess the associated health and socioeconomic impact, the Stent for Life economic project was launched and applied to four model regions: Romania, Portugal, the Basque Country in Spain, and the Kemerovo region in the Russian Federation. METHODS AND RESULTS: The Stent for Life economic model is based on a decision tree that incorporates primary percutaneous coronary intervention rates and mortality. Healthcare costs and indirect costs caused by loss of productivity were estimated. A baseline scenario simulating the status quo was compared to the Stent for Life scenario which integrated changes initiated by the Stent for Life programme. In the four model regions, primary percutaneous coronary intervention numbers rose substantially between 29-303%, while ST-elevation myocardial infarction mortality was reduced between 3-10%. Healthcare costs increased by 8% to 70%. Indirect cost savings ranged from 2-7%. Net societal costs were reduced in all model regions by 2-4%. CONCLUSION: The joint effort of the Stent for Life initiative and their local partners successfully saves lives. Moreover, the increase in healthcare costs was outweighed by indirect cost savings, leading to a net cost reduction in all four model regions. These findings demonstrate that systematic investments to improve the access of ST-elevation myocardial infarction patients to guideline-coherent therapy is beneficial, not only for the individual, but also for the society at large.
No takes yet. Share an insight, caveat, or question.
Wein et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: